ES461101A2 - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
ES461101A2
ES461101A2 ES461101A ES461101A ES461101A2 ES 461101 A2 ES461101 A2 ES 461101A2 ES 461101 A ES461101 A ES 461101A ES 461101 A ES461101 A ES 461101A ES 461101 A2 ES461101 A2 ES 461101A2
Authority
ES
Spain
Prior art keywords
lower alkyl
hydroxy
ring
het
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461101A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Publication of ES461101A2 publication Critical patent/ES461101A2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Mejoras introducidas en el objeto de la patente principal nº 434.542 por: procedimiento para preparar compuestos antagonistas de receptores H-2 de histamina de fórmula **fórmula ** en la que Het es una anillo piridina, tiazol, isotiazol, oxazol, isoxazol, tiadiazol, pirimidina, pirazina o piridazina, cuyo anillo está opcionalmente sustituido por alquilo inferior, alcoxi inferior, hidroxi, halógeno o amino Y es hidrógeno, hidroxi o alquilo inferior, y X es azufre, VHNO2 o NY'' en donde Y'' es hidrógeno, hidroxi, alquilo inferior, ciano o CONH2; W es NH o , cuando NY y X son ambos NH, azufre, q es un entero de 2 a 12 ; n es 2 o 3 y m es 0, 1 o 2, de modo que la suma de m y n sea 3 4 o, excepto cuando X es NH, NOH, NCONH2 o N (alquilo inferior) y Het''es imidazol, triazol o pirazol, dicha suma de m y n es 2; Z es azufre o un grupo metileno, Het'' es un anillo heterociclico nitrogenado de 5 o 6 miembros, tal como imidazol, piridina, tiazol, isotiazol, oxazol, isoxazol, pirazol, triazol, triadiazol,pirimidina , pirazina o piridazina, cuyo anillo está opcionalmente sustituido por alquilo inferior, alcoxi inferior, hidroxi, halógeno o amino y sus sales de adición de ácido farmacéuticamente aceptables.Improvements introduced in the object of the main patent No. 434,542 by: process for preparing histamine H-2 receptor antagonist compounds of formula **formula ** in which Het is a pyridine, thiazole, isothiazole, oxazole, isoxazole, thiadiazole ring , pyrimidine, pyrazine or pyridazine, which ring is optionally substituted by lower alkyl, lower alkoxy, hydroxy, halogen or amino Y is hydrogen, hydroxy or lower alkyl, and X is sulfur, VHNO2 or NY'' where Y'' is hydrogen , hydroxy, lower alkyl, cyano, or CONH2; W is NH or , when NY and X are both NH, sulfur, q is an integer from 2 to 12 ; n is 2 or 3 and m is 0, 1 or 2 such that the sum of m and n is 3 4 o, except when X is NH, NOH, NCONH2 or N(lower alkyl) and Het'' is imidazole, triazole or pyrazole , said sum of m and n is 2; Z is sulfur or a methylene group, Het'' is a 5- or 6-membered nitrogen heterocyclic ring, such as imidazole, pyridine, thiazole, isothiazole, oxazole, isoxazole, pyrazole, triazole, triadiazole, pyrimidine, pyrazine or pyridazine, which ring it is optionally substituted by lower alkyl, lower alkoxy, hydroxy, halogen or amino and pharmaceutically acceptable acid addition salts thereof.

ES461101A 1976-07-28 1977-07-28 Heterocyclic compound Expired ES461101A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139376 1976-07-28

Publications (1)

Publication Number Publication Date
ES461101A2 true ES461101A2 (en) 1978-12-01

Family

ID=10322438

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461101A Expired ES461101A2 (en) 1976-07-28 1977-07-28 Heterocyclic compound

Country Status (14)

Country Link
JP (1) JPS5315371A (en)
AU (1) AU2734777A (en)
BE (1) BE857219R (en)
DE (1) DE2733952A1 (en)
DK (1) DK331977A (en)
ES (1) ES461101A2 (en)
FI (1) FI772294A7 (en)
FR (1) FR2359841A1 (en)
IL (1) IL52545A0 (en)
LU (1) LU77865A1 (en)
NL (1) NL7708379A (en)
NO (1) NO772669L (en)
PL (1) PL199909A1 (en)
ZA (1) ZA774221B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (en) 1978-11-16 1980-08-14 Glaxo Group Ltd POLYMETHYLENE DERIVATIVES DISUBSTITUTED IN ALPHA, OMEGA, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US5352831A (en) * 1987-09-02 1994-10-04 Ciba-Geigy Corporation Oligomeric cyanoguanidines
ATE70261T1 (en) * 1987-09-02 1991-12-15 Ciba Geigy Ag OLIGOMERIC CYANOGUANIDINES.
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR735087A (en) * 1930-09-01 1932-11-03 Anticoman Ges M B H Process for making polymethylene-biguanidine salts which dissolve easily in water and in gastric juice
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas

Also Published As

Publication number Publication date
IL52545A0 (en) 1977-10-31
JPS5315371A (en) 1978-02-13
FR2359841A1 (en) 1978-02-24
LU77865A1 (en) 1977-10-24
NL7708379A (en) 1978-01-31
NO772669L (en) 1978-01-31
FI772294A7 (en) 1978-01-29
DE2733952A1 (en) 1978-02-02
DK331977A (en) 1978-01-29
BE857219R (en) 1978-01-27
AU2734777A (en) 1979-02-01
PL199909A1 (en) 1978-11-20
ZA774221B (en) 1978-06-28

Similar Documents

Publication Publication Date Title
HUP9802865A2 (en) N-(substituted phenyl)-pyrazole-derivatives, preparation and use thereof, parasiticidal compositions containing these compounds as active ingredients
DE10299018I2 (en) Heterocyclic compounds.
GB1490306A (en) 3-amino-indazolecarboxylic acid derivatives process for their preparation and their use as medicaments
NO975987L (en) 4-Phenylaminothiazole derivatives, process for their preparation and pharmaceutical compositions containing said derivatives
TR199901055T2 (en) Crystals of benzimidazole derivatives and their production.
CO5170518A1 (en) N- (BENZOCICLOALQUILO) COMPOUNDS DERIVED FROM AMINO ARALIFATICOS
KR870000323A (en) Method for preparing heteroaromatic amine derivative
FI942635A0 (en) Piperazine derivatives as 5HT1A antagonists
NO924522L (en) OPTICAL ACTIVE AZOL COMPOUNDS, THEIR MANUFACTURING AND USE
ES8603374A1 (en) Glycerin derivatives.
NO177007C (en) Analogous Process for Preparing Therapeutically Active Tetrahydrobenzimidazole Derivatives
GR3031693T3 (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
GB1493931A (en) Guanidines isothioureas and thioureas
ATE6511T1 (en) ANTISECRETORY GUANIDI DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR880006231A (en) Imidazolidinone compound and preparation method thereof
ES8800175A1 (en) 5-(Azolyloxyphenylcarbamoyl)-barbituric acid derivatives as active agents in anthelmics.
EA199901096A1 (en) CYANOGUANIDINES AS A CELL PROLIFERATION INHIBITOR
ES456735A1 (en) Amidinoformic and amidino-sulphinic acid derivatives
PT87025A (en) PROCESS FOR THE PREPARATION OF IMIDAZOL DERIVATIVES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
KR840006342A (en) Heterocyclic Compounds and Their Preparation
KR850004756A (en) Method for preparing 4,5,6,7-tetrahydro thiazolo [5,4-c] pyridine derivative
KR960703406A (en) Substituted arylthioalkylthiopyridine (SUBSTITUTED ARYLTHIOALKYLTHIOPYRDINES)
PL140272B1 (en) Herbicide and method of manufacture of novel derivatives of chloroacetamide
ZA892155B (en) Heterocyclic substituted 5,7-dihydropyrrolo(3,2-f)-benzoxazol-6-ones
KR910000141A (en) Use of isooxazolin-3-one derivatives as antidepressants